Half a decade after receiving a psychedelic treatment for depression, two-thirds of patients in a new study remained in ...

New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...

In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Psilocybin, the active ingredient in magic mushrooms, might just revolutionize how depression and anxiety are treated in ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

New Zealand approves use of ‘magic mushrooms’ to treat depression but only one psychiatrist is allowed to prescribe it - New ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...